Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 5/2016

30.05.2015 | Otology

Effect of intratympanic application of efinaconazole 10 % solution in the guinea pig

verfasst von: Kazuya Arakawa, Kazuhiro Nomura, Hidetoshi Oshima, Yohei Honkura, Ryoukichi Ikeda, Hiroshi Hidaka, Tetsuaki Kawase, Yukio Katori

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Efinaconazole 10 % solution is a new triazole antifungal agent developed for the topical treatment of fungal infections of the nails. The current study examined the effect of intratympanic application of efinaconazole 10 % solution in the guinea pig ear. Sixteen male Hartley guinea pigs (weight 501–620 g) were divided into 3 groups to be treated with efinaconazole 10 % solution, gentamicin (50 mg/mL), or saline solution. Topical solutions of 0.2 mL were applied through a small hole made at the tympanic bulla once daily for 7 consecutive days. Post-intervention auditory brainstem responses were obtained 7 days after the last treatment. The extent of middle ear damage and hair cell loss was investigated. The efinaconazole- and gentamicin-treated groups showed severe deterioration in auditory brainstem response threshold. Middle ear examination revealed extensive changes in the efinaconazole-treated group and medium changes in the gentamicin-treated group. Hair cells were preserved in the efinaconazole- and saline-treated groups, but severe damage was seen in the gentamicin group. In conclusion, efinaconazole 10 % solution applied intratympanically to the guinea pig middle ear caused significant middle ear inflammation and hearing impairment.
Literatur
3.
Zurück zum Zitat Marsh RR, Tom LW (1989) Ototoxicity of antimycotics. Otolaryngol Head Neck Surg 100:134–136CrossRefPubMed Marsh RR, Tom LW (1989) Ototoxicity of antimycotics. Otolaryngol Head Neck Surg 100:134–136CrossRefPubMed
5.
Zurück zum Zitat Zeichner JA, Stein Gold L, Korotzer A (2014) Penetration of ((14)C)-efinaconazole topical solution, 10 %, does not appear to be influenced by nail polish. J Clin Aesthet Dermatol 7:34–36PubMedPubMedCentral Zeichner JA, Stein Gold L, Korotzer A (2014) Penetration of ((14)C)-efinaconazole topical solution, 10 %, does not appear to be influenced by nail polish. J Clin Aesthet Dermatol 7:34–36PubMedPubMedCentral
10.
Zurück zum Zitat Kurnatowski P, Filipiak A (2001) Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses 44:472–479CrossRefPubMed Kurnatowski P, Filipiak A (2001) Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses 44:472–479CrossRefPubMed
13.
Zurück zum Zitat Del Rosso JQ (2014) The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. J Clin Aesthet Dermatol 7:10–18PubMedPubMedCentral Del Rosso JQ (2014) The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. J Clin Aesthet Dermatol 7:10–18PubMedPubMedCentral
14.
Zurück zum Zitat Del Rosso JQ, Reece B, Smith K, Miller T (2013) Efinaconazole 10 % solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential. J Clin Aesthet Dermatol 6:20–24 Del Rosso JQ, Reece B, Smith K, Miller T (2013) Efinaconazole 10 % solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential. J Clin Aesthet Dermatol 6:20–24
16.
Zurück zum Zitat Jo Siu WJ, Tatsumi Y, Senda H et al (2013) Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrob Agents Chemother 57:1610–1616. doi:10.1128/AAC.02056-12 CrossRefPubMedPubMedCentral Jo Siu WJ, Tatsumi Y, Senda H et al (2013) Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrob Agents Chemother 57:1610–1616. doi:10.​1128/​AAC.​02056-12 CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jarratt M, Siu WJ, Yamakawa E et al (2013) Safety and pharmacokinetics of efinaconazole 10 % solution in healthy volunteers and patients with severe onychomycosis. J Drugs Dermatol 12:1010–1016PubMed Jarratt M, Siu WJ, Yamakawa E et al (2013) Safety and pharmacokinetics of efinaconazole 10 % solution in healthy volunteers and patients with severe onychomycosis. J Drugs Dermatol 12:1010–1016PubMed
19.
20.
Zurück zum Zitat Morizono T, Sikora MA (1981) Ototoxicity of ethanol in the tympanic cleft in animals. Acta Otolaryngol 92:33–40CrossRefPubMed Morizono T, Sikora MA (1981) Ototoxicity of ethanol in the tympanic cleft in animals. Acta Otolaryngol 92:33–40CrossRefPubMed
Metadaten
Titel
Effect of intratympanic application of efinaconazole 10 % solution in the guinea pig
verfasst von
Kazuya Arakawa
Kazuhiro Nomura
Hidetoshi Oshima
Yohei Honkura
Ryoukichi Ikeda
Hiroshi Hidaka
Tetsuaki Kawase
Yukio Katori
Publikationsdatum
30.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 5/2016
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-015-3669-7

Weitere Artikel der Ausgabe 5/2016

European Archives of Oto-Rhino-Laryngology 5/2016 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.